Ayman Youssef Ezeldin Eassa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ayman Youssef Ezeldin Eassa has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Rabie
Department of Neurosurgery, University of Illinois at Chicago, Chicago, IL 60612, USA
1 shared publication - Ahmed Shakal
Department of Neurosurgery, Tanta University, Tanta, Egypt
1 shared publication - Konstantin V. Slavin
University of Illinois Chicago
1 shared publication - Leo Verhagen Metman
Rush University Medical Center, Chicago, IL, USA
1 shared publication - Mazen Fakhry
Department of Neurosurgery, Alexandria University, Alexandria, Egypt
1 shared publication - Wael Fouad
Alexandria Faculty of Medicine Neurosurgery Department Alexandria Egypt
1 shared publication
Latest Publications
- Open Access
- 13 December 2016
- Published by MDPI AG in Brain Sciences
- Vol. 6 (4) , 58
Improvement of Advanced Parkinson’s Disease Manifestations with Deep Brain Stimulation of the Subthalamic Nucleus: A Single Institution Experience
We present our experience at the University of Illinois at Chicago (UIC) in deep brain stimulation (DBS) of the subthalamic nucleus (STN), describing our surgical technique, and reporting our clinical results, and morbidities. Twenty patients with advanced Parkinson’s disease (PD) who underwent bilateral STN-DBS were studied. Patients were assessed preoperatively and followed up for one year using the Unified Parkinson’s Disease Rating Scale (UPDRS) in “on” and “off” medication and “on” and “off” stimulation conditions. At one-year follow-up, we calculated significant improvement in all the motor aspects of PD (UPDRS III) and in activities of daily living (UPDRS II) in the “off” medication state. The “off” medication UPDRS improved by 49.3%, tremors improved by 81.6%, rigidity improved by 50.0%, and bradykinesia improved by 39.3%. The “off” medication UPDRS II scores improved by 73.8%. The Levodopa equivalent daily dose was reduced by 54.1%. The UPDRS IVa score (dyskinesia) was reduced by 65.1%. The UPDRS IVb score (motor fluctuation) was reduced by 48.6%. Deep brain stimulation of the STN improves the cardinal motor manifestations of the idiopathic PD. It also improves activities of daily living, and reduces medication-induced complications.
- 13 December 2016
- Published by MDPI AG in Brain Sciences
- Vol. 6 (4) , 58
Open AccessImprovement of Advanced Parkinson’s Disease Manifestations with Deep Brain Stimulation of the Subthalamic Nucleus: A Single Institution Experience
We present our experience at the University of Illinois at Chicago (UIC) in deep brain stimulation (DBS) of the subthalamic nucleus (STN), describing our surgical technique, and reporting our clinical results, and morbidities. Twenty patients with advanced Parkinson’s disease (PD) who underwent bilateral STN-DBS were studied. Patients were assessed preoperatively and followed up for one year using the Unified Parkinson’s Disease Rating Scale (UPDRS) in “on” and “off” medication and “on” and “off” stimulation conditions. At one-year follow-up, we calculated significant improvement in all the motor aspects of PD (UPDRS III) and in activities of daily living (UPDRS II) in the “off” medication state. The “off” medication UPDRS improved by 49.3%, tremors improved by 81.6%, rigidity improved by 50.0%, and bradykinesia improved by 39.3%. The “off” medication UPDRS II scores improved by 73.8%. The Levodopa equivalent daily dose was reduced by 54.1%. The UPDRS IVa score (dyskinesia) was reduced by 65.1%. The UPDRS IVb score (motor fluctuation) was reduced by 48.6%. Deep brain stimulation of the STN improves the cardinal motor manifestations of the idiopathic PD. It also improves activities of daily living, and reduces medication-induced complications.